Latest News articles in ICU

More than forty randomised trials have evaluated early mobilisation and rehabilitation in ICUs in the last decade. These trials usually aim to reduce the incidence of ICU acquired weakness (ICUAW) which is known to be associated with poor long-term survival, poor physical function and decreased qua

Acute respiratory distress syndrome (ARDS) occurs in approximately 40% of patients with severe acute brain injury (sABI), including acute ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage and traumatic brain injury. It is also a major determinant of morbidity and mortality. &nb

Our population is ageing, and with increasing longevity, the prevalence of chronic conditions is also increasing. Multimorbidity is thus becoming a major challenge in the world of critical care.   Multimorbidity refers to the co-occurrence of two or more chronic conditions in an individual.

In an interesting discussion at the 40th ISICEM International Symposium on Intensive Care & Emergency Medicine,  Richard Wunderink, Professor of Medicine, Pulmonary and Critical Care Division of Northwestern University’s Feinberg School of Medicine and Medical Director, Medical ICU, Northw

A study was conducted to evaluate the efficacy and safety of baricitinib, an oral selective Janus kinase 1/2 inhibitor, in combination with standard of care for the treatment of hospitalised patients with COVID-19. A total of 1525 participants were enrolled from 101 centres across 12 countries

Results from the awake prone positioning for COVID-19 acute hypoxaemic respiratory failure meta-trial were presented by Oriol Roca, Critical Care Specialist, Vall d'Hebron University Hospital, Barcelona, Spain, at the 40th ISICEM International Symposium on Intensive Care & Emergency Medici